Top compounds associated with response to KMT2D


Feature Type Standardized
Nominal ANOVA
mRNA clofarabine CTRPv2 pan-cancer AAC 0.16 8e-07
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.2 9e-07
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA SN-38 CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.18 7e-06
Download CSV